Home › Funds › FCPM III SERVICES B.V. › MPLT
FCPM III SERVICES B.V. position in MPLT
MAPLIGHT THERAPEUTICS INC · Health Care
FCPM III SERVICES B.V. reported holding 3,226,400 shares of MPLT (MAPLIGHT THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$115.6M, representing 15.41% of its reported portfolio and ranking #2 among its reported holdings. FCPM III SERVICES B.V. has disclosed MPLT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How FCPM III SERVICES B.V.'s MPLT position evolved
FCPM III SERVICES B.V. first disclosed a stake in MPLT in Q4 2025 at 3,226,400 shares (US$56.7M). The position peaked in Q2 2026 at 3,226,400 shares, worth US$115.6M. Across 3 filings, FCPM III SERVICES B.V. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 3,226,400 shares valued at US$115.6M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 3.23M | $56.67M | New |
| Q1 2026 | 3.23M | $65.59M | Hold |
| Q2 2026 | 3.23M | $115.63M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MPLT and 13F data
MPLT (MAPLIGHT THERAPEUTICS INC) is a Health Care company. 118 other funds we track also report a position in MPLT — the largest reported positions include Novo Holdings A/S (US$132.1M), Nan Fung Group Holdings Ltd (US$34.8M), 5AM Venture Management, LLC (US$34.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MPLT
- Novo Holdings A/S 3.69M sh · $132.13M · Q2 2026
- Nan Fung Group Holdings Ltd 971.25K sh · $34.81M · Q2 2026
- 5AM Venture Management, LLC 950.01K sh · $34.05M · Q2 2026
- Sanofi 912.04K sh · $32.69M · Q2 2026
- Blue Owl Capital Holdings LP 729.93K sh · $26.16M · Q2 2026
- Paradigm Biocapital Advisors LP 685.85K sh · $24.58M · Q2 2026
- Pivotal bioVenture Partners Investment Advisor LLC 611.45K sh · $21.91M · Q2 2026
- Velan Capital Investment Management LP 492.89K sh · $17.67M · Q2 2026
- DAFNA Capital Management LLC 171.01K sh · $6.13M · Q2 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 125.43K sh · $4.50M · Q2 2026
- STEMPOINT CAPITAL LP 106.91K sh · $3.83M · Q2 2026
More on FCPM III SERVICES B.V.
FAQ
How long has FCPM III SERVICES B.V. held MPLT?
FCPM III SERVICES B.V. has disclosed MPLT holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is FCPM III SERVICES B.V.'s current position in MPLT?
As of Q2 2026, FCPM III SERVICES B.V. holds 3.23M shares of MPLT (MAPLIGHT THERAPEUTICS INC), valued at $115.63M, representing 15.41% of its reported portfolio and ranking #2.
Has FCPM III SERVICES B.V. been buying or selling MPLT?
In the latest 13F filing (Q2 2026), FCPM III SERVICES B.V. held unchanged its position in MPLT. The position peaked in Q2 2026 at 3.23M shares.
Which other funds hold MPLT?
Other major institutional holders of MPLT include Novo Holdings A/S, Nan Fung Group Holdings Ltd, 5AM Venture Management, LLC, among 118 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.